The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Communications and UpdatesFull Access

Questions on Conflict of Interest

To the Editor: We are writing to inquire about how the Journal handles issues of conflict of interest, both financial and intellectual. We raise these questions in the interest of stimulating discussion and encouraging greater transparency, not because we believe there is necessarily one right answer to any question.

What is the operational basis of the Editor's evaluation for possible influence from disclosed financial relationships? Given that such influences can be difficult for nonspecialists to detect and may operate beyond the awareness of authors themselves, what criteria are used to judge whether influence has occurred?

  • 1) Is potential conflict of interest one of the criteria taken into account when inviting authors of editorials or review articles? For example, if faced with a choice of several possible authors, does the Journal give preference to those without potential conflicts of interest, all other factors being equal?

  • 2) Does the Journal's conflict of interest policy take into account so-called intellectual conflict of interest as well as financial conflict of interest? Some professional societies are beginning to pay attention to this type of conflict in relationship to practice guidelines (1).

Restrictions on authorship have costs of their own, including exclusion of the contributions of experts in a field, and should not be undertaken lightly. However, the argument for preferring authors without financial relationships with industry seems particularly strong in the case of editorials and reviews, the value of which resides principally in the reliance that readers can place on the opinions of the authors. Advocating norms of this sort is not to suggest that industry relationships are necessarily problematic in themselves, but recognizes that certain activities may be incompatible with playing an active role in developing treatment recommendations for the field, as is the case for the development of DSM-5 (2).

Baltimore, M.D.
New York, N.Y.

accepted for publication in August 2010.

Dr. Gorelick is supported by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health. Dr. Appelbaum has an equity interest in COVR, Inc.

References

1. Guyatt G , Akl EA , Hirsh J , Kearon C , Crowther M , Gutterman D , Lewis SZ , Nathanson I , Jaeschke R , Schunemann H : The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 2010; 152:738–741Crossref, MedlineGoogle Scholar

2. http://www.dsm5.org/about/Pages/BoardofTrusteePrinciples.aspx Google Scholar